Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson’s disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson’s disease
Authors
Keywords
Parkinson disease, Cognitive impairment, Neuropsychological testing, Learning, Biomarkers, Dementia, Attention, Cognitive neurology
Journal
PLoS One
Volume 12, Issue 10, Pages e0186508
Publisher
Public Library of Science (PLoS)
Online
2017-10-25
DOI
10.1371/journal.pone.0186508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors
- (2016) Felix P. Bernhard et al. PLoS One
- Plasma Insulin-Like Growth Factor 1 Is Associated with Cognitive Impairment in Parkinson's Disease
- (2015) Jianfang Ma et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Potential sex differences in nonmotor symptoms in early drug-naive Parkinson disease
- (2015) R. Liu et al. NEUROLOGY
- Serum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson’s Disease: A Meta-Analysis
- (2015) Dun-Hui Li et al. PLoS One
- Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy
- (2014) A. J. Westwood et al. NEUROLOGY
- Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?
- (2014) Fares Bassil et al. PROGRESS IN NEUROBIOLOGY
- Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease
- (2013) M. T. Pellecchia et al. EUROPEAN JOURNAL OF NEUROLOGY
- Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson’s disease
- (2013) Marina Picillo et al. JOURNAL OF NEUROLOGY
- Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy
- (2013) Ayaka Numao et al. PARKINSONISM & RELATED DISORDERS
- The many faces of insulin-like peptide signalling in the brain
- (2012) Ana M. Fernandez et al. NATURE REVIEWS NEUROSCIENCE
- Serum Insulinlike Growth Factor 1 as Possible Marker for Risk and Early Diagnosis of Parkinson Disease
- (2011) Jana Godau ARCHIVES OF NEUROLOGY
- Cognitive impairment in nondemented Parkinson's disease
- (2011) Paolo Barone et al. MOVEMENT DISORDERS
- Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism
- (2011) S. Pappata et al. NEUROLOGY
- Serum insulin like growth factor-1 is associated with working memory, executive function and selective attention in a sample of healthy, fit older adults
- (2011) D. Bellar et al. NEUROSCIENCE
- Increased serum insulin-like growth factor 1 in early idiopathic Parkinson's disease
- (2010) J. Godau et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Rescue of α-synuclein cytotoxicity by insulin-like growth factors
- (2009) Shyan-Yuan Kao BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Insulinlike Growth Factor-1, Insulinlike Growth Factor Binding Protein-1, and Cognitive Function in Older Men and Women
- (2009) Wael K. Al-Delaimy et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started